NEISVAC, suspension for injection in a pre-filled syringe. meningococcal vaccine polysaccharide of the groupe c (conjugate, adsorbed) syringe, 0.5 ml
Active ingredients: POLYOSIDE (DE O-ACÉTYLATÉ) DE NEISSERIA MENINGITIDIS, GROUPE C (SOUCHE C11) CONJUGUÉ À L'ANATOXINE TÉTANIQUE
Commercialized according to BDPMDispensing in France: Prescription only
Suspension for injectionsyringe, 0.5 mlintramusculaire
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- NEISVAC, suspension injectable en seringue préremplie. Vaccin méningococcique polyosidique du groupe C (conjugué, adsorbé)
- Pharmaceutical form
- suspension injectable
- Route of administration
- intramusculaire
- Presentation description
- 1 seringue(s) préremplie(s) en verre de 0,5 ml avec 2 aiguille(s)
- Marketing authorisation holder
- PFIZER HOLDING FRANCE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 30 Jun 2025
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
69261547CIP73627739CIP133400936277397Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| POLYOSIDE (DE O-ACÉTYLATÉ) DE NEISSERIA MENINGITIDIS, GROUPE C (SOUCHE C11) CONJUGUÉ À L'ANATOXINE TÉTANIQUEsuspension | 10 microgrammes · une dose de 0,5 mL | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.